(Q45335936)

13 December 2017

title

Induction of a melanoma-specific antibody response by a monovalent, but not a divalent, synthetic GM2 neoglycopeptide (English)

1 reference

13 December 2017

1 reference

2

1 reference

13 December 2017

7

1 reference

13 December 2017

S Bay

1

1 reference

13 December 2017

L Birikaki

3

1 reference

13 December 2017

C Ganneau

4

1 reference

13 December 2017

E Samain

5

1 reference

13 December 2017

Y-M Coïc

6

1 reference

13 December 2017

E Dériaud

8

1 reference

13 December 2017

C Leclerc

9

1 reference

13 December 2017

R Lo-Man

10

1 reference

13 December 2017

publication date

1 April 2009

1 reference

13 December 2017

1 reference

13 December 2017

volume

4

1 reference

13 December 2017

issue

4

1 reference

13 December 2017

page(s)

582-587

1 reference

Antibodies against tumor cell glycolipids and proteins, but not mucins, mediate complement-dependent cytotoxicity

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Human monoclonal antibody to ganglioside GM2 for melanoma treatment

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Gangliosides as therapeutic targets for cancer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

The case for polyvalent cancer vaccines that induce antibodies

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Carbohydrate vaccines as immunotherapy for cancer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Tumor cell reactivity mediated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibodies

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Automated oligosaccharide synthesis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Protein glycosylation: new challenges and opportunities.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Large-scale in vivo synthesis of the carbohydrate moieties of gangliosides GM1 and GM2 by metabolically engineered Escherichia coli

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Chemoenzymatic synthesis of GM3 and GM2 gangliosides containing a truncated ceramide functionalized for glycoconjugate synthesis and solid phase applications

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Chemical and chemoenzymatic synthesis of S-linked ganglioside analogues and their protein conjugates for use as immunogens

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Organic synthesis in pursuit of immunology: large-scale synthesis of peracetylated GM2 glycosylamino acid for preparation of a multiantigenic prostate cancer vaccine

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs targeting prostate and breast cancer: a synthetic route to anticancer vaccine candidates

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

New trends in carbohydrate-based vaccines

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Synthesis and biological evaluation of a multiantigenic Tn/TF-containing glycopeptide mimic of the tumor-related MUC1 glycoprotein

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Robust immune responses elicited by a fully synthetic three-component vaccine

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis(y) conjugates in mice

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Synthetic carbohydrate vaccines: synthesis and immunogenicity of Tn antigen conjugates.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Cu-catalyzed azide-alkyne cycloaddition

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

The growing applications of click chemistry

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

A Potentially Valuable Advance in the Synthesis of Carbohydrate-Based Anticancer Vaccines through Extended Cycloaddition Chemistry

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Synthesis of 2-alkoxy-8-hydroxyadenylpeptides: towards synthetic epitope-based vaccines

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Biosynthesis of conjugatable saccharidic moieties of GM2 and GM3 gangliosides by engineered E. coli

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Synthesis and in vitro activities of a spacer-containing glycophospholipid ligand of a lipopolysaccharide receptor involved in endotoxin tolerance

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900032

7 January 2021

Identifiers

DOI

10.1002/CMDC.200900032

1 reference

13 December 2017

1 reference